Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT00805480
What this trial is testing

Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 130
Early research (Phase 1)Study completedNCT02186626
What this trial is testing

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

Who this might be right for
West Nile Virus
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT00119171
What this trial is testing

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Who this might be right for
Solid Tumor Cancer
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Ended earlyNCT00550017
What this trial is testing

Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2)

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 39
Testing effectiveness (Phase 2)Study completedNCT00621244
What this trial is testing

Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma
Novartis Pharmaceuticals 175
Early research (Phase 1)Temporarily pausedNCT00003980
What this trial is testing

BIBX 1382 in Treating Patients With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
European Organisation for Research and Treatment of Cancer - EORTC 80
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Testing effectiveness (Phase 2)Looking for participantsNCT07286370
What this trial is testing

Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

Who this might be right for
Salmonella Infections
GlaxoSmithKline 537
Early research (Phase 1)Study completedNCT00127829
What this trial is testing

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic

Who this might be right for
Tumors
AstraZeneca 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06681636
What this trial is testing

Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

Who this might be right for
HPV InfectionCervical CancerAnogenital Cancer+1 more
National Institute of Hygiene and Epidemiology, Vietnam 300
Large-scale testing (Phase 3)Study completedNCT02765919
What this trial is testing

A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix

Who this might be right for
Squamous Cell Carcinoma of Cervix
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 30
Large-scale testing (Phase 3)Study completedNCT05219253
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

Who this might be right for
Herpes Zoster
GlaxoSmithKline 288
Testing effectiveness (Phase 2)WithdrawnNCT03029416
What this trial is testing

Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension

Who this might be right for
Neoplasm MetastasisCancerRadiation Therapy Complication
Ronald McGarry
Testing effectiveness (Phase 2)Study completedNCT04996264
What this trial is testing

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite

Who this might be right for
SnakebitesEnvenomingEnvenoming, Snake+1 more
Ophirex, Inc. 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05581875
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseNeoplasms+6 more
Hellenic Society of Hematology 48
Large-scale testing (Phase 3)Study completedNCT00270075
What this trial is testing

Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

Who this might be right for
Blood TransfusionBlood Transfusion, AutologousOrthopedic Procedures+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Large-scale testing (Phase 3)Ended earlyNCT00518687
What this trial is testing

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Who this might be right for
Staphylococcus AureusBacteremiaMediastinitis
Merck Sharp & Dohme LLC 8,031
Testing effectiveness (Phase 2)Study completedNCT03162614
What this trial is testing

Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults

Who this might be right for
Malaria
GlaxoSmithKline 154
Next Page